|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02160 MP CARDIOFLOW-B
Nominal 
2.800 -0.070 (-2.439%) | 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Turnover | 57,044 | 12.280% | 50,805 | 47,493 | 36,040 | 31,503 |
| Cost of Sales | (19,982) | 28.866% | (15,506) | (15,014) | (12,763) | (12,881) |
| Gross Profit | 37,062 | 4.994% | 35,299 | 32,480 | 23,277 | 18,621 |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 637 | -95.628% | 14,569 | (18,577) | (12,161) | 3,674 | |
| Profit / (Loss) on Disposal | 3,771 | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (7,210) | -16.792% | (8,665) | (9,105) | (9,951) | (551) | |
| Profit / (Loss) before Taxation | (18,035) | 177.419% | (6,501) | (65,485) | (64,792) | (28,653) | |
| Taxation | (789) | -19.817% | (984) | (1,123) | (444) | (96) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 5 | -99.069% | 537 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (18,819) | 170.855% | (6,948) | (66,608) | (65,237) | (28,750) | |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Net Finance Costs / (Income) | (5,495) | -45.616% | (10,104) | (11,639) | (4,771) | (755) |
| Depreciation & Amortisation | 21,729 | 12.173% | 19,371 | 10,399 | 11,229 | 6,969 |
| Directors' Emoluments | -- | -- | -- | 1,995 | 1,335 | 1,651 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -4.000 | 300.000% | -1.000 | -14.126 | -13.639 | -6.275 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | (0.062) | (0.055) | (0.054) |
| NBV per share ($) | 0.201 | -- | 0.631 | 0.684 | 0.820 | 1.010 |
| Remarks: | Real time quote last updated: 13/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -18,819 |
| %Change | 170.855% |
| EPS / (LPS) | USD -0.040 |
| NBV Per Share ($) | USD 0.201 |